Cyclic Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 1.00 M
- Company Age 4 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 13.70 Cr
- Revenue Growth %
- Profit Growth 11.82%
- Ebitda 13.60%
- Net Worth -16.19%
- Total Assets 9.05%
About Cyclic Life Sciences
Cyclic Life Sciences Private Limited (CLSPL) is a Private Limited Indian Non-Government Company incorporated in India on 21 August 2020 (Four years and five months 19 days old ). Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M.
The company currently has active open charges totaling ₹13.70 Cr.
Maddireddy Varun and Madireddy Reddy serve as directors at the Company.
Company Details
-
Location
Hyderabad, Telangana, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U24290TG2020PTC143024
-
Company No.
143024
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
21 Aug 2020
-
Date of AGM
15 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Cyclic Life Sciences?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Maddireddy Varun
|
Director | 21-Aug-2020 | Current |
|
Madireddy Reddy
|
Director | 21-Aug-2020 | Current |
Financial Performance of Cyclic Life Sciences.
Cyclic Life Sciences Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 11.82% increase in profit. The company's net worth observed a substantial decline by a decrease of 16.19%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Cyclic Life Sciences?
In 2023, Cyclic Life Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Covalent Laboratories Private LimitedMadireddy Reddy is a mutual person
-
Lonsdale Life Sciences Private LimitedMaddireddy Varun is a mutual person
Charges (Loans)
₹137.00 M
₹0
Charges Breakdown by Lending Institutions
- Others : 13.70 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 29 Feb 2024 | Others | ₹13.70 Cr | Open |
How Many Employees Work at Cyclic Life Sciences?
Cyclic Life Sciences has a workforce of 0 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Cyclic Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cyclic Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.